FINWIRES · TerminalLIVE
FINWIRES

Consumers Energy Breaks Ground on Four Cities Metro Pipeline Project in Michigan

-- CMS Energy (CMS) subsidiary Consumers Energy said Monday it has broken ground on the Four Cities Metro Pipeline project to replace an aging natural gas network spanning over 8 miles across Oakland and Macomb counties in Michigan.

The pipeline project traverses through Royal Oak, Clawson, Madison Heights, and Warren.

The company will initially target replacing sections of the pipeline in Royal Oak, Clawson, and Warren cities this year, and aims to complete the modernization of the entire network by 2029.

Consumers Energy supplies natural gas and electricity to 6.8 million residents in the state.

Price: $78.17, Change: $-0.28, Percent Change: -0.36%

Related Articles

Asia

Beijing Enlight Media Q1 Profit Falls 99%; Shares Down 8%

Beijing Enlight Media Co (SHE:300251) posted first-quarter attributable net profit of 23.3 million yuan, down 99% from 2.02 billion yuan the previous year.Earnings per share went down to 0.01 yuan from 0.69 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue fell 94% year over year to 190.6 million yuan from 2.97 billion yuan.Shares of the media company were down 8% in recent trade.

$SHE:300251
Asia

Enlight Media 2025 Profit Jumps 473%; Shares Fall 7%

Beijing Enlight Media (SHE:300251) posted 2025 attributable net profit of 1.67 billion yuan, up 473% from 292.0 million yuan the previous year.Earnings per share went up to 0.57 yuan from 0.10 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue jumped 155% year over year to 4.04 billion yuan from 1.59 billion yuan.Shares of the media company were down 7% in recent trade.

$SHE:300251
Asia

CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug

China Resources Double-Crane Pharmaceutical (SHA:600062) received approval from the National Medical Products Administration to change the marketing authorization holder of dienogest tablets, according to a Shanghai bourse filing on Wednesday.Under the approved supplementary application, the pharmaceutical company's subsidiary, CR Zizhu Pharmaceutical, becomes the marketing authorization holder, as well as the manufacturer of the endometriosis drug.

$SHA:600062